BA heads into the final week of June down nearly 5% on the week, with options traders quietly adding downside protection as the July 29 earnings date draws closer.
The most notable shift this week is in options positioning. The put/call ratio has moved above its recent average, running at 0.86 against a 20-day mean of 0.81 — about 1.5 standard deviations elevated. That reading is still well below the 52-week high of 1.03, so this isn't panic hedging. But the drift toward puts has been consistent over the past two weeks, reversing a period from late May when the PCR touched its yearly low of 0.72. Investors are quietly becoming more defensive as the earnings catalyst approaches.
The lending market tells a very different story — one of almost no short-side conviction. Availability is exceptionally loose at roughly 6,200%, meaning there are far more shares available to borrow than are actually being shorted. Short interest itself has eased about 5.7% over the past week to roughly 2.1% of the free float, its lowest level in at least a month. Borrow costs have also fallen sharply — down 24% week-on-week to just 0.37% annualised, a 30-day low. None of that points to a community of bears pressing the stock; if anything, shorts are quietly covering into the pull-back.
The Street remains broadly constructive but is running slightly stale on its most recent published views. The most recent analyst action in the data dates from mid-May, when Citigroup nudged its target up to $260 while maintaining its Buy rating. Prior to that, Morgan Stanley held its Equal-Weight at $250 and Wells Fargo initiated with Overweight at $250 in early April. The consensus target of around $270 implies roughly 25% upside from current levels of $216.71, though that gap reflects the continued uncertainty baked into the name rather than a straightforward re-rating call. On valuation, the trailing PE has compressed about 32 points over the past 30 days to 127x — still demanding, but the direction of travel matters: the EPS momentum factor ranks in the 99th percentile on a 30-day view and 94th on a 90-day view, suggesting forward estimates are moving in the right direction even as the absolute numbers remain stretched. The EV/EBITDA of 32x has also eased nearly two points over the same period.
The bull case rests on a recovering delivery cadence, rising commercial aircraft demand, and a debt-reduction trajectory that should gradually normalise the balance sheet. Bears point to regulatory overhang, competition, and the fragile quality of recent financial improvement — a read echoed in factor scores, where quality trails significantly relative to peers like RTX. The ORTEX short score has drifted down from 32.3 to 31.8 over the past two weeks, a modest softening that aligns with short interest unwinding rather than any new bearish catalyst.
Insider activity provides a small but genuine signal. The 90-day net position is marginally positive — a director purchased around $300,000 worth of stock in May at $218.50, close to where the stock trades today. The more notable fact is that the CEO and several executives sold shares in February at $236-237, a level the stock has not reclaimed since. That cluster of executive sales at higher prices is worth keeping in mind as the stock attempts to rebuild.
Among correlated peers, HXL is down about 2.5% on the week and FTAI off 0.5%, while ATRO bucked the sector trend with a 9% weekly gain — the aerospace supply chain remains uneven. The next focal point for BA is the Q2 earnings release on July 29, where the last print delivered a 6.8% one-day move higher; what matters then will be whether delivery volumes and cash burn trajectory are running ahead of the current cautious Street consensus.
See the live data behind this article on ORTEX.
Open BA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
